About us
Meet the team
At metaLead, we aim to develop innovative, safe and effective medications for metal-related diseases, enhancing patient’s quality of life. Our vision is to revolutionize chelation therapy; to ensure that our medications will become first-in-line treatments for various indications and conditions.
Dr. Michal Shoshan
Medicinal inorganic chemist
14+ years in metal-related drug dev.
Dr. Stefano Vavassori
Immunologist
15+ years experience in rare pediatric diseases
Valerie Thevenoz
Business Development
Dr. Tagwa Mohammed
Medicinal inorganic chemist
Dr. Luca Sauser
Medicinal inorganic chemist
Yaël Hodel
Health Science & Technology, neuroscience
Erica Pedron
Molecular biology, in vivo
Our board
Dr. Michal Shoshan
Medicinal inorganic chemist
14+ years in metal-related drug dev.
Dr. Vincent Forster
Pharmaceutical scientist | Co-founder and CEO Versantis AG
They trust us!
We are supported by top institutions within Switzerland and beyond, among them:
James Martin | Company name
